About this trial
The goal of this trial is to test the real-world efficacy of AL-STEADI, a fall prevention program, in seven assisted living centers. We will randomly assign 700 residents from seven assisted living centers who screen at-risk of falling to either existing fall monitoring protocols or the enhanced AL-STEADI fall prevention program. We will evaluate the effect of AL-STEADI on the rate of falls over 12 months. We will also closely monitor implementation fidelity in these seven assisted living centers.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
AL-STEADI
BehavioralSTEADI is an evidence-based falls prevention program developed by the CDC and tested in several community-based settings. STEADI involves universal fall screening, followed by personalized assessments and tailored interventions. Common, potentially modifiable causes of falls evaluated in STEADI include medication interactions or side effects, environmental hazards (e.g., floor rugs, thresholds), untreated visual impairment, low vitamin D, ill-fitting footwear, or low blood pressure. AL-STEADI is a modified version of STEADI for assisted living.
Usual Care Group
BehavioralTypical fall prevention practices, including increased monitoring by assisted living staff
Treatment groups
Trial outcomes
Primary outcomes
Fall rate
Number of staff documented falls per 12 non-censored person-months, among individuals who screen at-risk for falls
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: